Botulinum toxin (BoNT) in the correction of mimic wrinkles - the most common complications
DOI:
https://doi.org/10.12775/JEHS.2022.12.08.072Keywords
botulinum toxin, BoNT, aesthetic medicineAbstract
Introduction and purpose
Botulinum toxin (BoNT) products are commonly used to treat muscle spasms such as cervical dystonia as well as to treat expression lines. Serotype A of botulinum toxin is the strongest and is used in aesthetic medicine procedures. It provides predictable results while having few side effects. Nevertheless, complications may occur, such as: ptosis of the upper eyelid, drooping eyebrows, ectropia, double vision, xerophthalmia, falling corners of the mouth, dysphagia, hoarseness, local swelling, erythema, bruising, pain at the injection site, asymmetry.
The aim of the study is to discuss the most common complications after injection of the botulin toxin in the correction of mimic wrinkles.
Description of the state of knowledge
BoNT is a neurotoxin that acts on the neuromuscular junctions, inhibits the release of acetylcholine, consequently causing temporary chemical denervation. Muscle function begins to return approximately 3 months after injection and fully returns after 6 months. Comparison of clinical trials of botulinum toxin type A in aesthetic allowed for the quantification of the frequency of adverse effects:drooping eyelids (2.5%), drooping eyebrows (3.1%), disturbed eye sensation (3%) and lip asymmetry (6.9%). Complications after cosmetic botulinum toxin injections are rare, and those that do occur are usually mild and transient. These complications are technique dependent; the incidence decreases as the injection ability improves.
Summary
Side effects are rare, nevertheless, thorough knowledge of the patient's anatomy, medical history, possible complications related to the specific product and site of administration, and close monitoring are essential for safe, effective treatment and the achievement of satisfactory results.
References
Solish N, Carruthers J, Kaufman J, Rubio RG, Gross TM, Gallagher CJ. Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A. Drugs. 2021; 81(18): 2091–2101. doi: 10.1007/s40265-021-01631-w
Sundaram H, Signorini M, Liew S, Trindade de Almeida AR, Wu Y, Braz AV, Fagien S, Goodman GJ, Monheit G, Raspaldo H. Global Aesthetics Consensus: Botulinum Toxin Type A—Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications. Plast Reconstr Surg. 2016 Mar; 137(3): 518–529 doi: 10.1097/01.prs.0000475758.63709.23
Small R. Botulinum Toxin Injection for Facial Wrinkles. Am Fam Physician. 2014;90(3):168-175.
Kassir M, Gupta M, Galadari H, Kroumpouzos G, Katsambas A, Lotti T, Vojvodic A, Grabbe S, Juchems E, Goldust M. Complications of botulinum toxin and fillers: A narrative review. J Cosmet Dermatol 2020;19:570-573
Dressler D, Benecke R. Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehabil. 2007;29(23):1761-1768.
Sundaram H, Liew S, Signorini M, et al. Global Aesthetics Consensus Group: Hyaluronic acid fillers and botulinum toxin type A: Recommendations for combined treatment and special considerations to optimize outcomes in diverse patient populations. Plast Reconstr Surg [PMC free article]
Borba A, Matayoshi S, Rodrigues M. Avoiding Complications on the Upper Face Treatment With Botulinum Toxin: A Practical Guide. Aesthetic Plast Surg. 2022; 46(1): 385–394. doi: 10.1007/s00266-021-02483-1
Qaqish C. Botulinum toxin use in the upper face. Atlas Oral Maxillofac Surg Clin. 2016;24:95–103. doi: 10.1016/j.cxom.2016.05.006.
Klein AW. Contraindications and complications with the use of botulinum toxin. Clin Dermatol. 2004;22:66–75. doi: 10.1016/j.clindermatol.2003.12.026.
Brin MF, Boodhoo TI, Pogoda JM, et al. Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: A meta-analysis of individual patient data from global clinical registration studies in 1678 participants. J Am Acad Dermatol. 2009;61:961.e1–970.e1.
Carruthers A, Carruthers J. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin. Dermatol Surg. 1998; 24: 1189- 1194.
Klein AW. Complications and adverse reactions with the use of botulinum toxin. Dis Mon. 2002; 48: 336- 356.
Ferreira MC, Salles AG, Gimenez R, Soares MFD. Complications with the use of Botulinum Toxin Type A in facial rejuvenation: report of 8 Cases. Aesthetic Plast Surg. 2004;28:441–444. doi: 10.1007/s00266-004-0031-7.
Sethi N, Singh S, DeBoulle K, Rahman E. A review of complications due to the use of Botulinum Toxin A for cosmetic indications. Aesthetic Plast Surg. 2020 doi: 10.1007/s00266-020-01983-w.
Carruthers A, Carruthers J. Clinical indications and injection technique for the cosmetic use of Botulinum A Exotoxin. Dermatologic Surg. 1998;24:1189–1194. doi: 10.1111/j.1524-4725.1998.tb04097.x.
Vartanian AJ, Dayan SH. Complications of botulinum toxin A use in facial rejuvenation. Facial Plast Surg Clin North Am. 2005;13:1–10. doi: 10.1016/j.fsc.2004.04.008.
Matarasso A. Discussion: new indications for botulinum toxin type A in cosmetics: mouth and neck. Plast Reconstr Surg. 2003; 110: 86S- 87S.
Goldwyn R, Rohrich R. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Supplement to Plast Reconstr Surg. 2004; 114: 1S- 22S.
Matarasso SL, Matarasso A. Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytides. Plast Reconstr Surg. 2001; 108: 208- 214.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Monika Szwed, Jakub Szwed, Michał Dzikowski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 432
Number of citations: 0